Dr. Isabelle Boileau is a senior scientist in the Brain Health Imaging Centre at CAMH. She is head of the Addiction Imaging Research Group and associate director of the Brain Health Imaging Centre. She is an associate professor of Psychiatry and of Pharmacology & Toxicology and a member of the Institute of Medical Science at the University of Toronto.
Areas of Research
Dr. Isabelle Boileau’s lab focuses on the use of translational imaging approaches (i.e.: positron emission tomography imaging (PET) and magnetic resonance imaging (MRI)) to help test novel, targetable mechanisms of neuropsychiatric disorders, specifically addictions and trauma –related conditions. As Canada Research Chair in Endocannabinoid Imaging, part of her research program actively investigates the role of the endocannabinoid system in mental health.
View Dr. Boileau's publications on PubMed.